Manulife (Manufacturers Life Insurance)
CRBU icon

Manulife (Manufacturers Life Insurance)’s Caribou Biosciences CRBU Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-31,076
Closed -$28.4K – 2925
2025
Q1 		$28.4K Sell
31,076
-2,535
-8% -$3.29K ﹤0.01% 2877
2024
Q4 		$53.4K Sell
33,611
-1,501
-4% -$3.02K ﹤0.01% 2932
2024
Q3 		$68.8K Sell
35,112
-1,377
-4% -$2.82K ﹤0.01% 2951
2024
Q2 		$59.8K Buy
36,489
+5,244
+17% +$16.8K ﹤0.01% 2937
2024
Q1 		$161K Sell
31,245
-858
-3% -$5.29K ﹤0.01% 2672
2023
Q4 		$184K Buy
32,103
+4,135
+15% +$20.4K ﹤0.01% 2659
2023
Q3 		$134K Buy
27,968
+3,306
+13% +$20.5K ﹤0.01% 2715
2023
Q2 		$105K Buy
24,662
+2,583
+12% +$11.6K ﹤0.01% 2833
2023
Q1 		$117K Hold
22,079
– – ﹤0.01% 2708
2022
Q4 		$139K Buy
22,079
+108
+0.5% +$961 ﹤0.01% 2708
2022
Q3 		$232K Sell
21,971
-741
-3% -$6.91K ﹤0.01% 2490
2022
Q2 		$123K Buy
22,712
+2,163
+11% +$16.5K ﹤0.01% 2839
2022
Q1 		$189K Buy
20,549
+9,637
+88% +$102K ﹤0.01% 2795
2021
Q4 		$165 Buy
10,912
+1,165
+12% +$22.7K ﹤0.01% 2962
2021
Q3 		$233K Buy
+9,747
New +$238K ﹤0.01% 2873

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s CRBU Position: Q2 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of Caribou Biosciences (CRBU) in Q2 2025, closing a stake of 31,076 shares — an estimated $28.4K sold.

Manulife (Manufacturers Life Insurance) first reported a position in CRBU in Q3 2021 and held it in 15 quarters. The position peaked at $233K in Q3 2021. 129 funds tracked by Wall St. Rank hold CRBU as of Q2 2025.

  • Manulife (Manufacturers Life Insurance) reported no remaining Caribou Biosciences position as of Q2 2025 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 31,076 Caribou Biosciences shares in Q2 2025, an estimated $28.4K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Caribou Biosciences in Q3 2021 and held it in 15 quarters.
  • Manulife (Manufacturers Life Insurance)'s Caribou Biosciences position peaked at $233K in Q3 2021.
  • 129 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2025, filed 14 Aug 2025.